Trials / Withdrawn
WithdrawnNCT05558813
Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP)
Prospective Cardiac Magnetic Resonance Imaging Study in Duchenne Muscular Dystrophy (DMD-CMP)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- Male
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to describe the progression of tissular and functional myocardial abnormalities in patients with Duchenne muscular dystrophy using cardiac magnetic resonance imaging and blood biomarkers assays.
Detailed description
This study is to describe the progression of tissular (late gadolinium enhancement, T1, T2, ECV assessments) and functional (segmental and global contractility, strain) myocardial abnormalities in patients with Duchenne muscular dystrophy using cardiac magnetic resonance imaging and blood biomarkers assays (troponin I, NTproBNP). Comparison between baseline and 2-years assessments will be conducted.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Cardiac MRI | two cardiac MRIs with Gadolinum injection at 2-year intervals |
| BIOLOGICAL | Blood assays | blood samples for the determination of blood biomarkers of heart failure (BNP, NTproBNP) and for the constitution of a biological collection |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2029-02-01
- Completion
- 2029-04-01
- First posted
- 2022-09-28
- Last updated
- 2025-11-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05558813. Inclusion in this directory is not an endorsement.